CKD: Clinical Trials

1 trial for CKD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow CKD: new trials by email Literature Review of CKD trials Research Report on CKD

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin
Low dose erythropoietin, High dose erythropoietin - Anemia, CKD
Phase 4TerminatedVA Office of Research and Development52017-11-022020-08-13

Narrower conditions

Anemia (1)  ·  Atherosclerosis (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Vascular Diseases (1)

Interventions

Contraceptives, Oral (1)  ·  Erythropoietin (1)

Sponsors

VA Office of Research and Development (1)

Countries

United States (1)

Top investigators

Mark S. Segal, MD PhD (1)

NIH funding

I01CX001449 (1)